Lenny Rachitsky

Author, podcast host, and angel investor focusing on product, growth, and career advice in the tech industry.

Angel Investor Active Metro San Francisco, United States Est. 2020
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
total disclosed, rounds participated
Stages

About

Lenny Rachitsky is an American technology entrepreneur, newsletter author, and podcaster. He is best known for founding Lenny's Newsletter in 2020, a publication offering in-depth advice on product management, growth strategies, and career development in the tech industry. He also hosts Lenny's Podcast, which features interviews with tech industry leaders. Prior to these ventures, Rachitsky spent seven years at Airbnb, where he led growth initiatives after his startup Localmind was acquired by the company in 2012. He is also an active angel investor in AI, B2B SaaS, marketplaces, platforms, and consumer products.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

Portfolio by sector

Business Software1

Q&A

What is Lenny Rachitsky's primary investment focus?
Lenny Rachitsky is an angel investor with a focus on Business Software, as evidenced by their investment in Loops.
What is a notable portfolio company for Lenny Rachitsky?
A notable portfolio company for Lenny Rachitsky is Loops, an analytics platform for product and growth managers, which raised a $14M Seed round in November 2022.
What is Lenny Rachitsky's typical investment stage?
Lenny Rachitsky primarily invests in the Seed stage, as seen with their investment in Loops.
When did Lenny Rachitsky make their most recent recorded investment?
Lenny Rachitsky's most recent recorded investment was in November 2022.
What is the typical check size for Lenny Rachitsky?
Lenny Rachitsky's investment range is between $14M and $14M, based on available data.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2020

Radar intelligence

Patents

EPO5